SEARCH

Search Details

Takeda Ryo

Hokkaido University Hospital Oral disease and managementAssistant Professor

Researcher basic information

■ Degree
  • Ph.D, Hokkaido University, Mar. 2023
■ URL
researchmap URLホームページURL■ Various IDs
Researcher number
  • 21044083
ORCID IDJ-Global ID■ Research Keywords and Fields
Research Keyword
  • Dentistry
  • Oral surgery
  • Oral medicine
  • Infectious disease
  • COVID-19
  • Malignant tumor
  • Jaw Deformities
  • Taste disorder
Research Field
  • Life Science, Surgical dentistry
  • Life Science, Oral pathobiological science

Career

■ Career
Career
  • Apr. 2026 - Present
    Hokkaido University Department of Oral Diagnosis and Medicine, Assistant Professor
  • Apr. 2023 - Mar. 2026
    社会医療法人 北斗 北斗病院 歯科口腔外科
Educational Background
  • 北海道大学大学院歯学院 卒業
  • 北海道大学歯学部 卒業
  • 北海道札幌南高等学校 卒業

Research activity information

■ Awards
  • 2024, 令和6年度 北海道大学歯学部口腔外科同門会 若手学術奨励賞
  • Aug. 2023, 日本口腔科学会, 第77回日本口腔科学会 Rising Scientist賞
    洗口液中殺菌成分セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
  • May 2023, 日本口腔科学会, 第77回日本口腔科学会 優秀ポスター賞
    洗口液中殺菌成分セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
    武田 遼
  • 2023, 令和5年度 北海道大学歯学部口腔外科同門会 若手学術奨励賞
  • Oct. 2022, The 22nd International Vascular Biology Meeting, The JVBMO Young Investigator Travel Award
    Analysis of lung endotheliopathy in lethal mice infected with mouse-adapted SARS-CoV-2
    Ryo Takeda
  • Sep. 2022, 歯科基礎医学会, 第64回歯科基礎医学会学術大会 モリタ優秀発表賞(病理学分野)
    SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼
  • Mar. 2022, 日本血管生物医学会, Best Presentation Award at the 7th Young Investigator Meeting of the Society for Vascular Biology and Medicine
    Analysis of vascular pathology in COVID-19 aggravation using a mouse infection model
    武田 遼
■ Papers
  • Effectiveness of Zinc Replacement Therapy With Zinc Acetate Dihydrate in Patients With Taste Disorder Associated With Zinc Deficiency: An Observational Study
    Ryo Takeda; Ken‐ichiro Sakata; Jun Sato; Takuya Asaka; Haruhisa Watanabe; Erika Akahori; Yasushi Kato; Tatsuki Itagaki; Keisuke Nakamura; Yurie Kondo Fujikawa; Yoshimasa Kitagawa
    Oral Science International, May 2026, [Peer-reviewed], [Lead author]
    English, Scientific journal, ABSTRACT

    Background/Objective
    Zinc deficiency is a major cause of taste disorders. The effectiveness rate of zinc replacement therapy is approximately 70%, irrespective of the cause of deficiency. However, the effectiveness of this therapy in our department is lower than that reported in the field of otolaryngology. In this study, we examined the effectiveness of zinc replacement therapy in patients with taste disorder.


    Methods
    We administered zinc preparations (zinc acetate dihydrate [Nobelzin︎], 50 mg/day) to 22 patients (7 men and 15 women) who visited our hospital for > 12 weeks. The cause, time to effect, serum zinc level, and other parameters were evaluated to assess improvement in taste disorder. Improvement in taste disorder was defined as a subjective expression comparing conditions before and after the 12‐week administration of zinc acetate dihydrate.


    Results
    The overall improvement rate among the patients was 77% (17/22). Serum zinc levels were elevated in 86% (19/22) of patients.


    Conclusions
    Zinc acetate dihydrate is a promising treatment for zinc‐deficiency‐associated taste disorders.
  • Antiviral effect of cetylpyridinium chloride on SARS-CoV-2 in patients with COVID-19: An Observational Study
    Ryo Takeda; Hirofumi Sawa; Michihito Sasaki; Yasuko Orba; Nako Maishi; Takuya Tsumita; Yoichi Ohiro; Akira Hasebe; Hidehiko Sano; Yoshimasa Kitagawa; Kyoko Hida; Yasuhiro Hida
    Journal of Oral Biosciences, Apr. 2026, [Peer-reviewed], [Lead author]
    Scientific journal
  • SARS-CoV-2 uptake and inflammatory response in senescent endothelial cells are regulated by the BSG/VEGFR2 pathway
    Yuya Sakurai; Yoichiro Fujioka; Nako Maishi; Ryo Takeda; Yusuke Ohba; Michihito Sasaki; Takahito Teshirogi; Wataru Ito; Yasuhiro Hida; Aya Matsuda; Kanta Kido; Yasuko Orba; Hirofumi Sawa; Kyoko Hida
    Proceedings of the National Academy of Sciences, 122, 31, Proceedings of the National Academy of Sciences, 28 Jul. 2025
    Scientific journal, Aging is a risk factor for severe COVID-19, characterized by vascular endothelial dysfunction. Although possible susceptibility of vascular endothelial cells (ECs) to SARS-CoV-2 infection has been suggested, the details of entry into cells have not been clarified. Previously, we reported that in an aged mouse model of severe COVID-19, ECs show a massive viral uptake and inflammatory response. Here, we focused on the endocytic capacity of senescent ECs. We found that the senescent ECs showed high endocytic capacity and SARS-CoV-2 virus uptake. This triggers an nuclear factor-kappa B (NF-κB) pathway–mediated inflammatory response. Further, Basigin enhanced endocytosis in the senescent ECs by activating the intracellular vascular endothelial growth factor signaling. Thus, EC senescence is associated with enhanced SARS-CoV-2 endocytosis and subsequent vascular endothelial dysfunction. This could prove a potential target for treating severe COVID-19 in older adults.
  • SARS-CoV-2 infection promotes lung thrombosis by inducing integrinβ3 expression in vascular endothelial cells
    Wataru Ito; Yuya Sakurai; Nako Maishi; Ryo Takeda; Takahito Teshirogi; Li Yu; Yasuhiro Hida; Michihito Sasaki; Yasuko Orba; Takuya Tsumita; Haruhisa Watanabe; Tadahiro Iimura; Terufumi Kubo; Shinsuke Toba; Akihiko Sato; Aya Matsuda; Daisuke Kyuno; Makoto Osanai; Yoichi Ohiro; Toshihiko Torigoe; Hirofumi Sawa; Kyoko Hida
    Scientific Reports, 15, 1, Springer Science and Business Media LLC, 01 Jul. 2025
    Scientific journal
  • Viral uptake and pathophysiology of the lung endothelial cells in age‐associated severe SARS‐CoV‐2 infection models
    Takuya Tsumita§; Ryo Takeda§; Nako Maishi; Yasuhiro Hida; Michihito Sasaki; Yasuko Orba; Akihiko Sato; Shinsuke Toba; Wataru Ito; Takahito Teshirogi; Yuya Sakurai; Tomohiro Iba; Hisamichi Naito; Hitoshi Ando; Haruhisa Watanabe; Amane Mizuno; Toshiki Nakanishi; Aya Matsuda; Ren Zixiao; Ji‐Won Lee; Tadahiro Iimura; Hirofumi Sawa; Kyoko Hida; §These authors contributed equally to this work
    Aging Cell, 23, 2, Wiley, 14 Dec. 2023, [Peer-reviewed], [Lead author]
    Scientific journal, Abstract

    Thrombosis is the major cause of death in severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, and the pathology of vascular endothelial cells (ECs) has received much attention. Although there is evidence of the infection of ECs in human autopsy tissues, their detailed pathophysiology remains unclear due to the lack of animal model to study it. We used a mouse‐adapted SARS‐CoV‐2 virus strain in young and mid‐aged mice. Only mid‐aged mice developed fatal pneumonia with thrombosis. Pulmonary ECs were isolated from these infected mice and RNA‐Seq was performed. The pulmonary EC transcriptome revealed that significantly higher levels of viral genes were detected in ECs from mid‐aged mice with upregulation of viral response genes such as DDX58 and IRF7. In addition, the thrombogenesis‐related genes encoding PLAT, PF4, F3 PAI‐1, and P‐selectin were upregulated. In addition, the inflammation‐related molecules such as CXCL2 and CXCL10 were upregulated in the mid‐aged ECs upon viral infection. Our mouse model demonstrated that SARS‐CoV‐2 virus entry into aged vascular ECs upregulated thrombogenesis and inflammation‐related genes and led to fatal pneumonia with thrombosis. Current results of EC transcriptome showed that EC uptake virus and become thrombogenic by activating neutrophils and platelets in the aged mice, suggesting age‐associated EC response as a novel finding in human severe COVID‐19.
  • Low-dose metronomic cisplatin as an antiangiogenic and anti-inflammatory strategy for cancer
    Hiroshi Kikuchi; Nako Maishi; Li Yu; Zi Jia; Cong Li; Masumi Sato; Ryo Takeda; Keita Ishizuka; Yasuhiro Hida; Nobuo Shinohara; Kyoko Hida
    British Journal of Cancer, 130, 2, 336, 345, Springer Science and Business Media LLC, 01 Dec. 2023
    Scientific journal
  • miR-1246 in tumor extracellular vesicles promotes metastasis via increased tumor cell adhesion and endothelial cell barrier destruction.
    Masahiro Morimoto; Nako Maishi; Takuya Tsumita; Mohammad Towfik Alam; Hiroshi Kikuchi; Yasuhiro Hida; Yusuke Yoshioka; Takahiro Ochiya; Dorcas A Annan; Ryo Takeda; Yoshimasa Kitagawa; Kyoko Hida
    Frontiers in oncology, 13, 973871, 973871, 2023, [Peer-reviewed], [International Magazine]
    English, Scientific journal, BACKGROUND: Tumor blood vessels play a key role in tumor metastasis. We have previously reported that tumor endothelial cells (TECs) exhibit abnormalities compared to normal endothelial cells. However, it is unclear how TECs acquire these abnormalities. Tumor cells secrete extracellular vesicles (EVs) to create a suitable environment for themselves. We have previously identified miR-1246 to be more abundant in high metastatic melanoma EVs than in low metastatic melanoma EVs. In the current study, we focused on miR-1246 as primarily responsible for acquiring abnormalities in TECs and examined whether the alteration of endothelial cell (EC) character by miR-1246 promotes cancer metastasis. METHODS: We analyzed the effect of miR-1246 in metastatic melanoma, A375SM-EVs, in vivo metastasis. The role of tumor EV-miR-1246 in the adhesion between ECs and tumor cells and the EC barrier was addressed. Changes in the expression of adhesion molecule and endothelial permeability were examined. RESULTS: Intravenous administration of A375SM-EVs induced tumor cell colonization in the lung resulting in lung metastasis. In contrast, miR-1246 knockdown in A375SM decreased lung metastasis in vivo. miR-1246 transfection in ECs increased the expression of adhesion molecule ICAM-1 via activation of STAT3, followed by increased tumor cell adhesion to ECs. Furthermore, the expression of VE-Cadherin was downregulated in miR-1246 overexpressed EC. A375SM-EV treatment enhanced endothelial permeability. VE-Cadherin was validated as the potential target gene of miR-1246 via the target gene prediction database and 3' UTR assay. CONCLUSION: miR-1246 in high metastatic tumor EVs promotes lung metastasis by inducing the adhesion of tumor cells to ECs and destroying the EC barrier.
  • The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation
    Li YU; Nako Maishi; Erika Akahori; Akira Hasebe; Ryo Takeda; Aya Yanagawa Matsuda; Yasuhiro Hida; Jin‐Min Nam; Yasuhito Onodera; Yoshimasa Kitagawa; Kyoko Hida
    Cancer Science, 113, 11, 3980, 3994, Wiley, Nov. 2022
    English, Scientific journal
  • Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2
    Ryo Takeda; Hirofumi Sawa; Michihito Sasaki; Yasuko Orba; Nako Maishi; Takuya Tsumita; Natsumi Ushijima; Yasuhiro Hida; Hidehiko Sano; Yoshimasa Kitagawa; Kyoko Hida
    Scientific Reports, 12, 1, Springer Science and Business Media {LLC}, 18 Aug. 2022, [Peer-reviewed], [Lead author]
    English, Scientific journal, AbstractCetylpyridinium chloride (CPC), a quaternary ammonium compound, which is present in mouthwash, is effective against bacteria, fungi, and enveloped viruses. This study was conducted to explore the antiviral effect of CPC on SARS-CoV-2. There are few reports on the effect of CPC against wild-type SARS-CoV-2 at low concentrations such as 0.001%–0.005% (10–50 µg/mL). Interestingly, we found that low concentrations of CPC suppressed the infectivity of human isolated SARS-CoV-2 strains (Wuhan, Alpha, Beta, and Gamma) even in saliva. Furthermore, we demonstrated that CPC shows anti-SARS-CoV-2 effects without disrupting the virus envelope, using sucrose density analysis and electron microscopic examination. In conclusion, this study provided experimental evidence that CPC may inhibit SARS-CoV-2 infection even at lower concentrations.
  • The Roles of Tumor Endothelial Cells in Cancer Metastasis
    Kyoko Hida; Nako Maishi; Ryo Takeda; Yasuhiro Hida
    Exon Publications, 03 May 2022
    English, Tumor metastasis is the main cause of cancer-related deaths. Tumor metastasis is orchestrated by a complex network of biological events. One such event is the formation of new blood vessels, termed as tumor angiogenesis. Tumor angiogenesis is essential for tumor progression. Without tumor angiogenesis, most solid tumors remain dormant. Apart from supplying tumors with nutrients and oxygen, tumor blood vessels provide a route for metastasis. Endothelial cells are key players in the formation of neovessels. Tumor endothelial cells that line tumor blood vessels differ from normal endothelial cells in many aspects. Tumor endothelial cells are irregular monolayers, have a higher expression of proangiogenic factors, and impaired endothelial barrier function when compared with their normal counterparts. The basement membrane thickness of tumor blood vessels is uneven and the association between pericytes and tumor endothelial cells is weak, leading to vascular leakiness. In this chapter, we highlight the role of endothelial cells in the initial steps of tumor metastasis.
  • Clinical study of patients with oral dysesthesia
    Hiroyuki HATO; Ken-ichiro SAKATA; Jun SATO; Takuya ASAKA; Haruhisa WATANABE; Ryo TAKEDA; Noritaka OHGA; Yutaka YAMAZAKI; Yoshimasa KITAGAWA
    Japanese Journal of Oral and Maxillofacial Surgery, 67, 7, 422, 432, Japanese Society of Oral and Maxillofacial Surgeons, 20 Jul. 2021
    Scientific journal
  • Drug-induced Taste Disorder in Dentistry
    KEN-ICHIRO SAKATA; TATSUKI ITAGAKI; TAKASHI IORI; NORITAKA OHGA; RYO TAKEDA; HARUHISA WATANABE; YOSHIMASA KITAGAWA
    Japanese Journal of Oral Diagnosis / Oral Medicine, 34, 2, 101, 105, The Japanese Society of Oral Diagnosis/Oral Medicine, Jun. 2021
    Scientific journal
  • Chemotherapy-Induced IL8 Upregulates MDR1/ABCB1 in Tumor Blood Vessels and Results in Unfavorable Outcome
    Hiroshi Kikuchi; Nako Maishi; Dorcas A. Annan; Mohammad Towfik Alam; Randa Ibrahim Hassan Dawood; Masumi Sato; Masahiro Morimoto; Ryo Takeda; Keita Ishizuka; Ryuji Matsumoto; Tomoshige Akino; Kunihiko Tsuchiya; Takashige Abe; Takahiro Osawa; Naoto Miyajima; Satoru Maruyama; Toru Harabayashi; Manabu Azuma; Katsushige Yamashiro; Kaname Ameda; Akira Kashiwagi; Yoshihiro Matsuno; Yasuhiro Hida; Nobuo Shinohara; Kyoko Hida
    Cancer Research, 15 Jul. 2020
    Scientific journal
  • Clinical Study of Patients with the Primary Burning Mouth Syndrome
    Hiroyuki HATO; Ken-ichiro SAKATA; Jun SATO; Takuya ASAKA; Haruhisa WATANABE; Ryo TAKEDA; Noritaka OHGA; Chiharu SATOH; Yoshimasa KITAGAWA
    Journal of Japanese Society of Oral Medicine, 26, 1, 8, 15, Japanese Society of Oral Medicine, Jun. 2020
    Scientific journal
  • 舌痛症に対する立効散の効果と安全性の検討
    坂田 健一郎; 浅香 卓哉; 武田 遼; 北川 善政
    日本歯科東洋医学会誌, 38, 1-2, 62, 62, 日本歯科東洋医学会, Aug. 2019, [Peer-reviewed]
    Japanese
  • 口腔内異常感症に対する半夏厚朴湯の効果
    武田 遼; 坂田 健一郎; 浅香 卓哉; 北川 善政
    日本歯科東洋医学会誌, 38, 1-2, 62, 62, 日本歯科東洋医学会, Aug. 2019, [Peer-reviewed]
    Japanese
  • 口腔内異常感症に対する半夏厚朴湯の効果
    武田 遼; 坂田健一郎; 浅香卓哉; 佐藤 淳; 佐藤 明; 大賀則孝; 羽藤裕之; 庵 敬; 北川善政
    痛みと漢方, 29, 103, 107, Jun. 2019, [Peer-reviewed], [Lead author]
■ Other Activities and Achievements
  • 亜鉛欠乏性味覚障害に対する酢酸亜鉛水和物の効果
    武田 遼; 坂田 健一郎; 佐藤 淳; 浅香 卓哉; 大賀 則孝; 渡辺 陽久; 北川 善政, 日本口腔診断学会雑誌, 34, 1, 63, 63, Feb. 2021
    (一社)日本口腔診断学会, Japanese
  • 亜鉛欠乏性味覚障害に対する酢酸亜鉛水和物の効果
    武田 遼; 坂田 健一郎; 佐藤 淳; 浅香 卓哉; 大賀 則孝; 渡辺 陽久; 北川 善政, 日本口腔内科学会雑誌, 26, 2, 111, 111, Dec. 2020
    (一社)日本口腔内科学会, Japanese
  • 亜鉛欠乏性味覚障害に対し亜鉛製剤2剤を用いて治療を行った1例
    渡辺 陽久; 坂田 健一郎; 佐藤 淳; 浅香 卓哉; 大賀 則孝; 羽藤 裕之; 庵 敬; 武田 遼; 北川 善政, 日本口腔科学会雑誌, 69, 2, 76, 76, Jul. 2020
    (NPO)日本口腔科学会, Japanese
  • 舌痛症に対する立効散の効果と安全性の検討
    坂田 健一郎; 浅香 卓哉; 武田 遼; 北川 善政, 日本歯科東洋医学会学術大会, 36回, 32, 32, Oct. 2018
    日本歯科東洋医学会, Japanese
  • 口腔内異常感症に対する半夏厚朴湯の効果
    武田 遼; 坂田 健一郎; 浅香 卓哉; 北川 善政, 日本歯科東洋医学会学術大会, 36回, 33, 33, Oct. 2018
    日本歯科東洋医学会, Japanese
■ Books and other publications
  • Metastasis
    Kyoko Hida; Nako Maishi; Ryo Takeda; Yasuhiro Hida, Chapter 10The Roles of Tumor Endothelial Cells in Cancer Metastasis
    Exon Publications, Mar. 2022, [Joint work]
■ Lectures, oral presentations, etc.
  • 仮想整復模型を用いた下顎骨骨折の治療経験
    武田 遼; 和田 麻友美; 佐藤 健彦; 高野 昌士
    第52回 日本口腔外科学会北日本支部学術集会, 30 May 2026
  • 下顎智歯部の顎骨嚢胞摘出後に下顎骨骨折をきたした2例
    武田 遼; 和田 麻友美; 佐藤 健彦; 高野 昌士
    第51回 日本口腔外科学会 北日本支部学術集会, 31 May 2025, Oral presentation
  • 当科でのMRONJ治療 ~Extensive surgeryはいつ,どのような範囲で行いますか?~
    武田 遼; 和田 麻友美; 佐藤 健彦; 高野 昌士
    若手口腔外科医交流会第3回学術集会, 10 May 2025, Oral presentation
  • MRONJ下顎骨切除標本中に乳癌転移が認められた1例
    武田 遼; 和田 麻友美; 佐藤 健彦; 高野 昌士; 北村 哲也; 牧野 修治郎
    第43回日本口腔腫瘍学会総会, 27 Feb. 2025, Oral presentation
  • 磁場式ナビゲーションシステムを使用し,口腔外から下顎埋伏智歯抜歯を行った1例
    武田 遼; 佐藤 健彦; 和田 麻友美; 高野 昌士
    第69回公益社団法人 日本口腔外科学会総会・学術大会, 23 Nov. 2024, Oral presentation
  • 磁場式ナビゲーションシステムを使用し,口腔外から下顎埋伏智歯抜歯を行った1例
    武田 遼; 高野 昌士; 佐藤 健彦; 牧野 修治郎
    北海道病院歯科医会令和6年度第2回例会, 07 Sep. 2024, Oral presentation
  • 頬部に発生した結節性筋膜炎の1例
    武田 遼; 高野 昌士; 佐藤 健彦; 北村 哲也; 牧野 修治郎
    第50回日本口腔外科学会北日本支部学術集会, 06 Jul. 2024, Oral presentation
  • 当院におけるMRONJ術後予後不良例
    武田 遼; 高野 昌士; 佐藤 健彦; 牧野 修治郎
    北海道病院歯科医会令和6年度第1回例会, 15 Jun. 2024, Public symposium
  • 両側頸部に後発転移した下顎歯肉原発紡錘細胞扁平上皮癌の1例
    武田 遼; 高野 昌士; 佐藤 健彦; 牧野 修治郎
    第68回 日本口腔外科学会総会・学術大会, 11 Nov. 2023, Oral presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼,間石 奈湖,松田 彩,北川 善政,樋田 京子
    第76回 NPO法人日本口腔科学会学術集会, 21 Apr. 2023, Poster presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼; 積田 卓也; 澤 洋文; 大場 靖子; 佐々木 道仁; 鳥羽 晋輔; 伊藤 航; 樋田 泰浩; 間石 奈湖; 樋田 京子
    第112回日本病理学会総会, 14 Apr. 2023, Invited oral presentation
    [Invited]
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼; 伊藤 航; 手代木孝仁; 佐々木道仁; 大場靖子; 間石奈湖; 松田 彩; 佐藤彰彦; 鳥羽晋輔; 李 智媛; 飯村忠浩; 樋田泰浩; 北川善政; 澤 洋文; 樋田京子
    第30回日本血管生物医学会学術集会, 16 Dec. 2022, Oral presentation
    [Invited]
  • Analysis of lung endotheliopathy in lethal mice infected with mouse-adapted SARS-CoV-2
    Ryo Takeda; Hirofumi Sawa; Michihito Sasaki; Yasuko Orba; Nako Maishi; Wataru Ito; Takahito Teshirogi; Yoshimasa Kitagawa; Yasuhiro Hida; Kyoko Hida
    The 22nd International Vascular Biology Meeting(IVBM2022), 16 Oct. 2022, English, Poster presentation
  • 洗口液中殺菌成分セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
    武田 遼; 間石 奈湖; 松田 彩; 樋田 京子
    第33回日本臨床口腔病理学会, 23 Sep. 2022, Poster presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    Ryo Takeda; Nako Maishi; Kyoko Hida
    第64回歯科基礎医学会学術大会, 18 Sep. 2022, Poster presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼; 伊藤 航; 間石 奈湖; 松田 彩; 北川 善政; 樋田 京子
    第60回特定非営利活動法人日本口腔科学会北日本地方部会, 10 Jul. 2022, Oral presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼; 間石 奈湖; 松田 彩; 北川 善政; 樋田 京子
    第76回 NPO法人日本口腔科学会学術集会, 21 Apr. 2022, Poster presentation
  • SARS-CoV-2感染マウスを用いた肺血管内皮細胞の重症化関連遺伝子の解析
    武田 遼; 積田 卓也; 澤 洋文; 大場 靖子; 佐々木 道仁; 鳥羽 晋輔; 伊藤 航; 樋田 泰浩; 間石 奈湖; 樋田 京子
    第111回日本病理学会総会, 14 Apr. 2022, Oral presentation
  • Analysis of vascular pathology in COVID-19 aggravation using a mouse infection model
    Ryo Takeda; Takuya Tsumita; Wataru Ito; Ren Zixiao; Amane Mizuno; Hirofumi Sawa; Michihito Sasaki; Nako Maishi; Aya Matsuda; Yasuhiro Hida; Akihiko Sato; Shinsuke Toba; Kentaro Uemura; Hironori Tanaka; Ji-Won Lee; Yoshimasa Kitagawa; Kyoko Hida
    第7回血管生物医学会若手研究会, 05 Mar. 2022, Oral presentation
    優秀賞受賞
  • セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
    武田 遼
    令和3年度北海道歯学会2月例会, 18 Feb. 2022, Oral presentation
  • 洗口液中殺菌成分セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
    武田 遼; 間石奈湖; 樋田京子
    第63回歯科基礎医学会学術大会, 09 Oct. 2021, Poster presentation
  • セチルピリジニウム塩化物水和物のSARS-CoV-2に対する効果
    武田 遼; 澤 洋文; 佐々木 道仁; 大場 靖子; 鳥羽 晋輔; 上村 健太朗; 佐藤 彰彦; 積田 卓也; 田中 宏典; 任 子驍; 樋田 泰浩; 間石 奈湖; 北川 善政; 樋田 京子
    第101回北海道医学大会(病理),第54回北海道病理談話会, 18 Sep. 2021, Oral presentation
  • 亜鉛欠乏性味覚障害に対する酢酸亜鉛水和物の効果
    武田 遼; 坂田 健一郎; 佐藤 淳; 浅香 卓哉; 大賀 則孝; 渡辺 陽久; 北川 善政
    第30回日本口腔内科学会学術集会, Oct. 2020, Oral presentation
  • 亜鉛欠乏性味覚障害に対する酢酸亜鉛水和物投与の有効性
    武田 遼; 坂田 健一郎; 佐藤 淳; 浅香 卓哉; 大賀 則孝; 渡辺 陽久; 北川 善政
    第74回NPO法人 日本口腔科学会 学術大会, May 2020, Oral presentation
  • 口腔内異常感症に対する半夏厚朴湯の効果
    武田 遼; 坂田 健一郎; 浅香 卓哉; 北川 善政
    第45回 (公社) 日本口腔外科学会 北日本支部学術集会, May 2019, Poster presentation
  • 口腔内異常感症に対する半夏厚朴湯の効果
    武田 遼; 坂田 健一郎; 浅香 卓哉; 北川 善政
    第36回日本歯科東洋医学会学術大会, Oct. 2018, Poster presentation
  • 抗癌剤治療による腫瘍血管内皮細胞の薬剤耐性獲得機構
    武田 遼; 菊地 央; 間石 奈湖; 樋田 京子
    第59回 歯科基礎医学会学術大会, Sep. 2017, Poster presentation
■ Affiliated academic society
  • Japanese Society of Oral Implantology
  • 日本顎変形症学会
  • 日本口腔内科学会
  • Japanese Society of Oral Oncology
  • Japanese Stomatological Society
  • Japanese Society of Oral and Maxillofacial Surgeons